skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,789  for All Library Resources

Results 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up
Material Type:
Article
Add to My Research

Effectiveness of Heart Failure Checklist Management in Patients with Chronic Heart Failure: An Open-Label, Single-Center Controlled Study During 18 Months of Follow-Up

Therapeutics and clinical risk management, 2023-11, Vol.19, p.983-992 [Peer Reviewed Journal]

COPYRIGHT 2023 Dove Medical Press Limited ;ISSN: 1178-203X ;ISSN: 1176-6336 ;EISSN: 1178-203X ;DOI: 10.2147/TCRM.S417426

Full text available

2
Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway
Material Type:
Article
Add to My Research

Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway

Pharmaceutical biology, 2019-01, Vol.57 (1), p.48-54 [Peer Reviewed Journal]

2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2019 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2019.1569697 ;PMID: 30905241

Full text available

3
The association between COPD and heart failure risk: a review
Material Type:
Article
Add to My Research

The association between COPD and heart failure risk: a review

International journal of chronic obstructive pulmonary disease, 2013-01, Vol.8 (default), p.305-312 [Peer Reviewed Journal]

COPYRIGHT 2013 Dove Medical Press Limited ;COPYRIGHT 2013 Dove Medical Press Limited ;2013 De Miguel Díez et al, publisher and licensee Dove Medical Press Ltd 2013 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/copd.s31236 ;PMID: 23847414

Full text available

4
Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats
Material Type:
Article
Add to My Research

Qiliqiangxin improves cardiac function and attenuates cardiac remodelling in doxorubicin-induced heart failure rats

Pharmaceutical biology, 2020-01, Vol.58 (1), p.417-426 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2020.1761403 ;PMID: 32429724

Full text available

5
Patients with Heart Failure During and After Inpatient Cardiac Rehabilitation
Material Type:
Article
Add to My Research

Patients with Heart Failure During and After Inpatient Cardiac Rehabilitation

Vascular health and risk management, 2021-01, Vol.17, p.49-58 [Peer Reviewed Journal]

2021 Schürmann et al. ;COPYRIGHT 2021 Dove Medical Press Limited ;2021. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Schürmann et al. 2021 Schürmann et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S276465 ;PMID: 33623387

Full text available

6
Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches
Material Type:
Article
Add to My Research

Heart failure with preserved ejection fraction: strategies for disease management and emerging therapeutic approaches

Postgraduate medicine, 2021-02, Vol.133 (2), p.125-139 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2020.1842620 ;PMID: 33283589

Digital Resources/Online E-Resources

7
Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system
Material Type:
Article
Add to My Research

Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system

Postgraduate medicine, 2021-02, Vol.133 (2), p.140-145 [Peer Reviewed Journal]

2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2020 ;ISSN: 0032-5481 ;EISSN: 1941-9260 ;DOI: 10.1080/00325481.2020.1842621 ;PMID: 33131371

Digital Resources/Online E-Resources

8
Targeting heart failure with preserved ejection fraction: current status and future prospects
Material Type:
Article
Add to My Research

Targeting heart failure with preserved ejection fraction: current status and future prospects

Vascular health and risk management, 2016-01, Vol.12 (Issue 1), p.129-141 [Peer Reviewed Journal]

COPYRIGHT 2016 Dove Medical Press Limited ;COPYRIGHT 2016 Dove Medical Press Limited ;2016. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Kanwar et al. This work is published and licensed by Dove Medical Press Limited 2016 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S83662 ;PMID: 27143907

Full text available

9
Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease
Material Type:
Article
Add to My Research

Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease

International journal of chronic obstructive pulmonary disease, 2015-01, Vol.10, p.515-523 [Peer Reviewed Journal]

2015. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2015 Kubota et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2015 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S79942 ;PMID: 25784798

Full text available

10
Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
Material Type:
Article
Add to My Research

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives

Vascular health and risk management, 2017-01, Vol.13, p.369-382 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Yandrapalli et al. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/vhrm.s114784 ;PMID: 29042791

Full text available

11
Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care
Material Type:
Article
Add to My Research

Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care

International journal of chronic obstructive pulmonary disease, 2014-01, Vol.9 (default), p.785-794 [Peer Reviewed Journal]

COPYRIGHT 2014 Dove Medical Press Limited ;COPYRIGHT 2014 Dove Medical Press Limited ;2014. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2014 Theander et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License 2014 ;ISSN: 1178-2005 ;ISSN: 1176-9106 ;EISSN: 1178-2005 ;DOI: 10.2147/COPD.S62563 ;PMID: 25071370

Full text available

12
Platelet, Neutrophil and Lymphocyte Quantitative Abnormalities in Patients with Heart Failure: A Retrospective Study
Material Type:
Article
Add to My Research

Platelet, Neutrophil and Lymphocyte Quantitative Abnormalities in Patients with Heart Failure: A Retrospective Study

Vascular health and risk management, 2023-01, Vol.19, p.69-78 [Peer Reviewed Journal]

2023 Getawa and Bayleyegn. ;COPYRIGHT 2023 Dove Medical Press Limited ;2023. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 Getawa and Bayleyegn. 2023 Getawa and Bayleyegn. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S394765 ;PMID: 36776273

Full text available

13
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
Material Type:
Article
Add to My Research

Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan

Vascular health and risk management, 2020-01, Vol.16, p.41-51 [Peer Reviewed Journal]

2020 Sokos and Raina. ;COPYRIGHT 2020 Dove Medical Press Limited ;2020. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Sokos and Raina. 2020 Sokos and Raina. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S197291 ;PMID: 32021227

Full text available

14
Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives
Material Type:
Article
Add to My Research

Spotlight on Spironolactone Oral Suspension for the Treatment of Heart Failure: Focus on Patient Selection and Perspectives

Vascular health and risk management, 2019-01, Vol.15, p.571-579 [Peer Reviewed Journal]

2019 Manolis et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Manolis et al. 2019 Manolis et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S210150 ;PMID: 31920323

Full text available

15
Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1/2 signalling
Material Type:
Article
Add to My Research

Paeonol attenuates heart failure induced by transverse aortic constriction via ERK1/2 signalling

Pharmaceutical biology, 2022-12, Vol.60 (1), p.562-569 [Peer Reviewed Journal]

2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2022 The Author(s) ;ISSN: 1388-0209 ;EISSN: 1744-5116 ;DOI: 10.1080/13880209.2022.2040543 ;PMID: 35249458

Full text available

16
The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device
Material Type:
Article
Add to My Research

The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device

Renal failure, 2023-12, Vol.45 (1), p.2157285-2157285 [Peer Reviewed Journal]

2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution – Non-Commercial License http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2023 The Author(s) ;ISSN: 0886-022X ;EISSN: 1525-6049 ;DOI: 10.1080/0886022X.2022.2157285 ;PMID: 36763000

Full text available

17
Pediatric ventricular assist devices: current challenges and future prospects
Material Type:
Article
Add to My Research

Pediatric ventricular assist devices: current challenges and future prospects

Vascular health and risk management, 2017-01, Vol.13, p.177-185 [Peer Reviewed Journal]

COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Burki and Adachi. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S82379 ;PMID: 28546755

Full text available

18
Machine learning model and nomogram to predict the risk of heart failure hospitalization in peritoneal dialysis patients
Material Type:
Article
Add to My Research

Machine learning model and nomogram to predict the risk of heart failure hospitalization in peritoneal dialysis patients

Renal failure, 2024-12, Vol.46 (1), p.2324071-2324071 [Peer Reviewed Journal]

2024 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2024 The Author(s) ;ISSN: 0886-022X ;EISSN: 1525-6049 ;DOI: 10.1080/0886022X.2024.2324071 ;PMID: 38494197

Full text available

19
The causes, consequences, and treatment of left or right heart failure
Material Type:
Article
Add to My Research

The causes, consequences, and treatment of left or right heart failure

Vascular health and risk management, 2011-01, Vol.7, p.237-254 [Peer Reviewed Journal]

2011. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2011 Pazos-López et al, publisher and licensee Dove Medical Press Ltd. 2011 ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S10669 ;PMID: 21603593

Full text available

20
B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey
Material Type:
Article
Add to My Research

B-Type Natriuretic Peptides (BNP) and Tissue Doppler E/e´ Before and After 4 Weeks Standard Treatment of African Heart Failure Subjects: The ABU-BNP Longitudinal Survey

Vascular health and risk management, 2019-01, Vol.15, p.559-569 [Peer Reviewed Journal]

2019 Onyemelukwe et al. ;2019. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2019 Onyemelukwe et al. 2019 Onyemelukwe et al. ;ISSN: 1178-2048 ;ISSN: 1176-6344 ;EISSN: 1178-2048 ;DOI: 10.2147/VHRM.S211498 ;PMID: 31908467

Full text available

Results 1 - 20 of 1,789  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 1992  (11)
  2. 1992 To 2003  (22)
  3. 2004 To 2010  (117)
  4. 2011 To 2018  (737)
  5. After 2018  (903)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,774)
  2. Reports  (14)
  3. Conference Proceedings  (1)
  4. More options open sub menu

Language 

  1. Japanese  (78)
  2. Norwegian  (2)
  3. Swedish  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait